IRCT2017080210222N10招募中3 期
Evaluation of Effect of pioglitazone on decreasing of proteinuria in type II diabetic patients and kidney disease.
Vice chancellor for research of Shahrekord University of Medical Science0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Inclution Criteria: 24-hour urine protein over 250 mg / day or the ratio of albumin to creatinine over 30 mg/g
排除标准
- •Hypothyroidism and heart failure; HbA1C is less than 8; Blood pressure less than 160/100; Creatinine less than 2; GFR greater than 50
研究者
相似试验
尚未招募
2 期
Pioglitazone and non-alcoholic fatty liveron-alcoholic fatty liver.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20210614051574N3Esfahan University of Medical Sciences44
已完成
2 期
Pioglitazone the treatment of schizophreniaschizophrenia.schizophreniaIRCT201110281556N30Tehran University of Medical Sciences30
已完成
不适用
A study to investigate the effect of pioglitazone on whole body and myocardial glucose uptake and myocardial blood flow/coronary vasodilator reserve in patients with familial combined hyperlipidaemiaISRCTN78563659Takeda Europe R and D Centre (UK)26
招募中
3 期
Effect of Pioglitazone and ClobetasolIRCT20210926052596N1Tehran University of Medical Sciences40
已完成
2 期
Study of efficacy and side effects of Pioglitazone in the treatment of psoriasisPsoriasis vulgarisPsoriasis.IRCT138903013862N2Research Council of Mashhad University of Medical Sciences26